Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 3 résultats.
    • Article de périodique
    Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial
    Jehn, U. Suciu, Stefan[UCL] Thomas, X. Lefrere, F. Muus, P. Berneman, Z. Marie, J-P Adamo, F. Fillet, G. Nobile, F. Ricciuti, F. Leone, G. Rizzoli, V. Montanaro, M. Beeldens, F. Fazi, P. Mandelli, F. Willemze, R. de Witte, T. Amadori, S. (2006) Leukemia — Vol. 20, no. 10, p. 1723-1730 (2006)
    • Communication
    Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups
    de Witte, T. Hagemeijer, Anne Suciu, Stefan[UCL] Belhabri, A Delforge, Michel Aul, C Aivado, M Selleslag, D. Schouten, H Ferrant, Augustin[UCL] Biersack, H Amadori, S. Muus, P. Jehn, U. Beeldens, F. Jansen, J Hellstrom-Lindberg, P Ossenkoppele, G Gratwohl, A. Marie, JP Willemze, R. (2006) 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group — Hamburg (Germany)
    • Article de périodique
    The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
    Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)